The 5th U.S. Circuit Court of Appeals in New Orleans ruled Wednesday that the Food and Drug Administration’s initial approval of mifepristone in 2000 should remain in effect.
US Abortion Landscape Shifts Yet Again Thanks To Ruling By Federal Appeals Court